Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population‐based study
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate the volumetric brain magnetic resonance imaging (MRI) findings in a population-based sample of systemic lupus erythematosus (SLE) patients and to detect a possible relationship between cerebral MRI abnormalities and specific neuropsychiatric (NP) manifestations. METHODS: The study population consisted of patients with SLE (n = 43) in Pirkanmaa Health Care District, Finland and of a sex- and age-stratified reference group from the general population (n = 43). In addition to a clinical neurological investigation, all subjects received a detailed neuropsychological assessment and an MRI study. Volumetric measures of cerebral atrophy as well as T1- and T2-weighted lesions were obtained. SLE activity was assessed by the European Consensus Lupus Activity Measure (ECLAM) index, and accumulated NP abnormalities were measured by the Systemic Lupus International Collaborating Clinics (SLICC) damage index. A cumulative lifetime dose of glucocorticoids was determined from the patientrecords. RESULTS: Compared with controls, SLE patients had increased volumes of both T1- and T2-weighted lesions (p = 0.019 and p<0.0001, respectively) and increased cerebral atrophy (p<0.001). All the measured MRI parameters were statistically significantly higher in NPSLE than in non-NPSLE patients. In SLE patients, cerebral atrophy was associated with cognitive dysfunction, epileptic seizures, and cerebrovascular disease; T1-weighted lesions were associated with epileptic seizures and T2-weighted lesions with cognitive dysfunction. All MRI parameters correlated significantly with the SLICC index but not with the ECLAM index. A positive correlation was found between a cumulative dose of glucocorticoids and cerebral atrophy in SLE patients. CONCLUSION: MRI abnormalities, including brain atrophy and T1- and T2-weighted lesions, are significantly more common in patients with SLE than in the general population and they are related to specific NP manifestations. Our findings also provide support for the organic aetiology of cognitive dysfunction in SLE.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, WMLs with or without infarcts are associated with cognitive deficits and neuropsychiatric disorders in patients with autoimmune disorders (eg, systemic lupus erythematosus, Sjögren disease).”
In the citing paper
“Treatment with statin therapy has been documented to protect against stroke, both in primary460 and secondary studies, based on data from meta-analysis36 and a single trial, Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL).461”
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
ACR AD HOC COMMITTEE ON NEUROPSYCHIATRIC LUPUS NOMENCLATURE (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199904)42:4<599::aid-anr2>3.0.co;2-f · Cited by 2,202
Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions
Brey, R. L., Holliday, S. L., Saklad, A. R., Navarrete, M. G., Hermosillo–Romo, D., Stallworth, C. L., Valdez, C. R., Escalante, A., del Rincón, I., Gronseth, G., et al. (2002) · Neurology · doi:10.1212/wnl.58.8.1214 · Cited by 595
The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus
Ainiala, H., Loukkola, J., Peltola, J., Korpela, M., & Hietaharju, A. (2001) · Neurology · doi:10.1212/wnl.57.3.496 · Cited by 484
Self-citationAiniala, H., Hietaharju, A., Loukkola, J., Peltola, J., Korpela, M., Metsänoja, R., & Auvinen, A. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200110)45:5<419::aid-art360>3.0.co;2-x · Cited by 339
Self-citationVitali, C., Bencivelli, W., Isenberg, D. A., Smolen, J. S., Snaith, M. L., Sciuto, M. E., Neri, R., & Bombardieri, S. (1992) · PubMed · Cited by 317
Signal transduction and transcription factors in rheumatic disease
Firestein, G. S., & Manning, A. M. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199904)42:4<609::aid-anr3>3.0.co;2-i · Cited by 198
Kozora, E., Thompson, L. L., West, S. G., & Kotzin, B. L. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391213 · Cited by 181
Jennekens, F. G. I., & Kater, L. (2002) · British journal of rheumatology · doi:10.1093/rheumatology/41.6.619 · Cited by 161
Sanna, G., Piga, M., Terryberry, J. W., Peltz, M. T., Giagheddu, S., Satta, L., Ahmed, A., Cauli, A., Montaldo, C., Passiu, G., et al. (2000) · Lupus · doi:10.1191/096120300678828695 · Cited by 160
Research works printed but not linked: 3
- Tanabe J., 1997, How do we use it to understand causes of clinical signs? Ann N Y Acad Sci, 823, 169
- Vitali C., 1992, Clin Exp Rheumatol, 10, 541
- Taccari E., 1994, Clin Exp Rheum, 12, 23
Cited by
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Bertsias, G. K., Ioannidis, J. P. A., Aringer, M., Bollen, E., Bombardieri, S., Bruce, I. N., Cervera, R., Dalakas, M., Doria, A., Hanly, J. G., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.130476 · Cited by 742
Classification of white matter lesions on magnetic resonance imaging in elderly persons
Kim, K. W., MacFall, J. R., & Payne, M. E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.024 · Cited by 539
Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers
Jeltsch-David, H., & Muller, S. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.148 · Cited by 304
Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations
Bertsias, G. K., & Boumpas, D. T. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.62 · Cited by 284
Metadata
- Authors
- Ainiala, H., Dastidar, P., Loukkola, J., Lehtimäki, T., Korpela, M., Peltola, J., & Hietaharju, A.
- Affiliations
- Departments of Neurology, Neurosurgery, and Rehabilitation
- Diagnostic Radiology
- Tampere University Hospital (FI)
- Corresponding author
- Ainiala, H.
- Venue
- Scandinavian Journal of Rheumatology
- Publisher
- Informa UK Limited
- Published
- 2005-12-31
- Volume
- 34
- Issue
- 5
- Pages
- 376-382
- ISSN
- 0300-9742 (ISSN-L)
- 1502-7732
- OpenAlex
- W2027011510
- Cited by
- 149
- References
- 22
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 6 · 2023: 2 · 2022: 6 · 2021: 13 · 2020: 4 · 2019: 5 · 2018: 13 · 2017: 8 · 2016: 9 · 2015: 9 · 2014: 12 · 2013: 5 · 2012: 11
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Scandinavian Journal of Rheumatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- systemic lupus erythematosus, neuropsychiatric lupus, brain MRI abnormalities, brain atrophy, T2-weighted lesions, cognitive impairment, epileptic seizures, cerebrovascular disease, glucocorticoid dose, SLICC/ACR damage index, brain volumetry
- MeSH terms
- Adult, Atrophy, Brain, Cognition Disorders, Epilepsy, Female, Glucocorticoids, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Lupus Vasculitis, Central Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population‐based study. https://app.cochat.ai/papers/10.1080/03009740510026643
- The paper
- Ainiala, H., Dastidar, P., Loukkola, J., Lehtimäki, T., Korpela, M., Peltola, J., & Hietaharju, A. (2005). Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population‐based study. Scandinavian Journal of Rheumatology. https://doi.org/10.1080/03009740510026643
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.